Bioengineering

Rice and Houston Methodist award seed grants for digital health research

The grants aim to accelerate the translation of technologies into clinical applications.

Rice’s Veiseh elected to the National Academy of Inventors

Rice bioengineer Omid Veiseh has been elected as a National Academy of Inventors Fellow, the highest professional distinction awarded to inventors.

Bioengineering graduate students learn about local health care issues in Rio Grande Valley

Rice bioengineering graduate students in the Global Medical Innovation program recently visited the Rio Grande Valley to better understand the unique challenges faced by communities in the region.

Rice Biotech Launch Pad hosts foundation representatives, Type 1 diabetes patients and advocates for campus tour

Representatives from Breakthrough T1D, a leading global organization funding Type 1 diabetes research, visited Rice to learn about advances in diabetes treatment.

Rice collaborators host inaugural convening to promote advancement of global cancer detection efforts

The Center for Innovation and Translation of POC Technologies for Equitable Cancer Care hosted its inaugural convening at Rice, marking a significant milestone in ongoing efforts to advance health equity in cancer care.

CPRIT leaders enjoy campus tour showcasing cancer research initiatives and capabilities

Senior officials from the Cancer Prevention and Research Institute of Texas visited Rice Nov.11 for a firsthand, comprehensive look at the university’s cancer-focused collaborative research initiatives and innovation-driven facilities and labs.

Researchers develop minimally invasive neural interface in revolutionary study

Researchers including Jacob Robinson have developed a technique for diagnosing, managing treating neurological disorders with minimal surgical risks.

‘Game changer’ in lithium extraction: Researchers develop novel electrochemical reactor

Researchers at Rice have developed an innovative electrochemical reactor to extract lithium from natural brine solutions, offering a promising approach to address the growing demand for lithium used in rechargeable batteries.

Rice bioengineers shed light on dosing challenges for cancer immunotherapy

A team of Rice bioengineers has developed a mathematical model that clarifies why interleukin-12 ⎯ a potent immune-boosting protein that holds promise for cancer treatment ⎯ loses effectiveness over time when used as an immunotherapeutic.

Rep. Dan Crenshaw hosts leading Rice bioengineer at health care innovation summit

Rice bioengineer Omid Veiseh joined U.S. Rep. Dan Crenshaw, R-Texas, in conversation at Crenshaw’s annual event showcasing health care innovation.

Cancer Bioengineering Collaborative hosts kickoff event, awards first round of seed grants

Leaders and researchers from Rice and the University of Texas MD Anderson Cancer Center came together this month to celebrate the launch of the Cancer Bioengineering Collaborative, first announced earlier this summer.

Rice360 conference convenes newborn and maternal health care community to discuss solutions through innovation

Newborn and maternal health experts, innovators and community leaders from around the world gathered at the inaugural “Innovation for Day One” conference hosted by the Rice360 Institute for Global Health Technologies. Conference attendees convened to take collective action on solving one of the most pressing global health challenges: improving maternal and newborn health in resource-limited settings.

Rice launches RBL LLC to rapidly create biotech startups focused on delivering breakthrough therapies to patients

Rice has launched RBL LLC, a pioneering biotech venture creation studio designed to rapidly build companies based on lifesaving medical technologies developed out of the Rice Biotech Launch Pad.

Rice bioengineers awarded $3.4M for project to end polio

Rice bioengineer Kevin McHugh has been awarded $3.4 million for a project to incorporate protection against polio into the combination vaccine that protects against five common and dangerous childhood diseases.

Rice’s Biotech Launch Pad to lead commercialization of bioelectrical implant treatment for obesity, Type 2 diabetes

Rice is part of multiuniversity research team that has secured $34.9 million from ARPA-H to accelerate the development of a bioelectronic implant designed to revolutionize treatment for obesity and Type 2 diabetes, improving patient experience and outcomes while reducing the development and manufacturing costs.